Clearday is a non-acute health care services company focused on servicing the largest demographic in the country – older Americans, who we define as adults that are 50 or more years of age. Clearday provides a modern, hopeful vision for making high-quality care more accessible, affordable, and empowering for older Americans and those who love and care for them. We operate four residential care facilities and a day care center that serve primarily older Americans, and persons facing cognitive issues such as Alzheimer’s and other forms of dementia. These facilities are our centers of cognitive excellence in which we have developed new care models that improve the experiences of our customers, their families and our care givers.
Company profile
Ticker
CLRD
Exchange
Website
CEO
Jeffrey Quiram
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Former names
SUPERCONDUCTOR TECHNOLOGIES INC
SEC CIK
Corporate docs
Subsidiaries
AIU 8800 Village Drive, LLC • AIU Alternative Care, Inc. • AIU Impact Management LLC • All In GP Company, LLC • Caerus Hospitality Partners, LLC • Caerus Hospitality, LLC • Cibolo Rodeo, Ltd • Clearday Alternative Care Oz Fund, LP • Clearday Clubs, Ltd • Clearday Management, LLC ...
IRS number
770158076
CLRD stock data
Latest filings (excl ownership)
8-K
Regulation FD Disclosure
26 Jan 23
8-K
Clearday Signs a Letter of Intent to Purchase a Property Portfolio
24 Jan 23
8-K
Entry into a Material Definitive Agreement
19 Jan 23
8-K
Regulation FD Disclosure
12 Jan 23
8-K
Entry into a Material Definitive Agreement
10 Jan 23
8-K
Entry into a Material Definitive Agreement
3 Jan 23
8-K
Regulation FD Disclosure
29 Dec 22
8-K
Entry into a Material Definitive Agreement
27 Dec 22
8-K
Regulation FD Disclosure
21 Dec 22
8-K
Clearday’s Companion Robot is Working in the Home Environment
30 Nov 22
Transcripts
CLRD
Earnings call transcript
2019 Q3
14 Nov 19
CLRD
Earnings call transcript
2019 Q2
13 Aug 19
CLRD
Earnings call transcript
2019 Q1
9 May 19
CLRD
Earnings call transcript
2018 Q4
21 Mar 19
CLRD
Earnings call transcript
2018 Q3
13 Nov 18
CLRD
Earnings call transcript
2018 Q2
14 Aug 18
CLRD
Earnings call transcript
2018 Q1
10 May 18
CLRD
Earnings call transcript
2017 Q4
22 Mar 18
CLRD
Earnings call transcript
2017 Q3
10 Nov 17
Financial summary
| Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 10.00 k | 10.00 k | 10.00 k | 10.00 k | 10.00 k | 10.00 k |
| Cash burn (monthly) | (no burn) | 46.21 k | 1.02 mm | 1.26 mm | 129.82 k | (no burn) |
| Cash used (since last report) | n/a | 190.72 k | 4.22 mm | 5.22 mm | 535.73 k | n/a |
| Cash remaining | n/a | -180.72 k | -4.21 mm | -5.21 mm | -525.73 k | n/a |
| Runway (months of cash) | n/a | -3.9 | -4.1 | -4.1 | -4.0 | n/a |
Institutional ownership, Q3 2022
8.1% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 1 |
| Opened positions | 0 |
| Closed positions | 1 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 1.55 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Cibolo Creek Partners | 1.55 mm | $0.00 |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Dec 22 | James Walesa | Common Stock | Buy | Acquire P | No | No | 0.6755 | 1,776,436 | 1.20 mm | 3,053,827 |
| 10 Jun 22 | Billie Jay Parrish | Common Stock, par value $0.001 per share | Buy | Acquire P | No | No | 0 | 13,033 | 0.00 | 303,595 |
| 10 Jun 22 | Alan H Channing | Common Stock, par value $0.001 per share | Buy | Acquire P | No | No | 0 | 24,453 | 0.00 | 128,174 |
| 10 Jun 22 | James Walesa | Common Stock | Buy | Acquire P | No | No | 0 | 157,407 | 0.00 | 1,277,391 |
| 20 Dec 21 | James Walesa | Common Stock | Buy | Acquire P | No | No | 3.068 | 121 | 371.23 | 1,119,984 |
| 17 Dec 21 | James Walesa | Common Stock | Buy | Acquire P | No | Yes | 2.983 | 3,000 | 8.95 k | 1,119,863 |
| 16 Dec 21 | James Walesa | Common Stock | Buy | Acquire P | No | Yes | 3.132 | 1,000 | 3.13 k | 1,116,863 |
Press releases
Clearday Retains ClearThink Capital to Explore Unlocking Value with SPACs
26 Jan 23
Clearday's Companion Robotics Robot Mitra Shows Tremendous Acceptance by TRECS Institute which Expanded their Grant Application Program Into 30 States for the 1st qtr. of 2023
11 Jan 23
Clearday's Companion Robotics Solution Mitra Selected for Pennsylvania Pilot Program
29 Dec 22
Clearday's "Companion Robotics" Chosen as a "Revolutionary Elder Care Solution" By TRECS Institute
21 Dec 22
Clearday's Companion Robot is Working in the Home Environment
1 Dec 22